Valve‐in‐valve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback